BioMérieux

Syndromic Multiplex Panels Market Research Report 2024: Global Analysis, Strategies, Trends and Forecasts to 2028 with Executive Guides - ResearchAndMarkets.com

Retrieved on: 
Friday, March 29, 2024
Medical Supplies, Medical Devices, Health, Technology, Infectious Diseases, Health Technology, PCR, Disease, POCT, SARS-CoV-2, RSV, DTC, BioMérieux, STI, Live

5.2.3 Infectious Disease is Declining But..

Key Points: 
  • 5.2.3 Infectious Disease is Declining But..
    5.2.5 Economic Growth improves Living Standards.
  • 5.3.14 Syndromics drives POCT adoption.
  • 6.2 BioMerieux Submits Application for Respiratory, Sore Throat Panel
    6.8 Altratech to Enter MDx, POC Space by Supplanting PCR
    6.21 Quidel Gains CE Mark for Savanna Analyzer, Respiratory Panel
    6.26 Binx Health Targeting Clinics, DTC & OTC With STI Tests
    6.27 Luminex Lands BARDA Grant to Develop Test for SARS-CoV-2, Flu, RSV
    6.29 MiRxes Receives Approval for Multiplex SARS-CoV-2, Flu Test

Co-Diagnostics, Inc. Appoints New President and Other C-Level Positions

Retrieved on: 
Thursday, April 4, 2024
PCR, Growth, New product development, Brigham Young University, Utah Valley University, COVID-19, M.B.A, Sale, University, Engineering, Laboratory, CCO, BioMérieux, Marketing, FDA, Management

Mr. Abbott holds a Master of Science degree from Brigham Young University and an M.B.A from the Wharton Business School.

Key Points: 
  • Mr. Abbott holds a Master of Science degree from Brigham Young University and an M.B.A from the Wharton Business School.
  • In his new role, Mr. Abbott will play a key role in the development and commercialization of the Co-Dx PCR platform and associated tests.
  • We welcome them in their new roles as the world continues its shift towards a more decentralized approach to diagnostics.
  • The Co-Dx PCR Pro instrument and Co-Dx COVID-19 Test are currently under review by the FDA.

United States Medical Diagnostics Research Report 2024: Market Impacts of Surging Adoption of Healthcare Wearables and Rising Integration with Artificial Intelligence - Forecasts to 2028 - ResearchAndMarkets.com

Retrieved on: 
Friday, March 8, 2024
Biotechnology, Health, Technology, Health Technology, Artificial Intelligence, Hospital, Pandemic, PMA, POC, Growth, EHR, Conditional sentence, Urbanization, BioMérieux, Quest Diagnostics, COVID-19, Product type, Abbott Laboratories, Automation, Danaher Corporation, Roche, Artificial intelligence, IVD, Medical device

A few notable trends include surging adoption of healthcare related devices like wearables, emergence of various pandemic diseases, rising integration with Artificial Intelligence and growing awareness for personalized medicine.

Key Points: 
  • A few notable trends include surging adoption of healthcare related devices like wearables, emergence of various pandemic diseases, rising integration with Artificial Intelligence and growing awareness for personalized medicine.
  • The U.S. medical diagnostics market has been segmented on the basis of type, product type and end-users.
  • Depending on the product type, the U.S. medical diagnostics market can be segmented into reagents, instruments and software & services.
  • The report provides a comprehensive analysis of the U.S. medical diagnostics market segmented on the basis of type, product type, end users and region.

Autoimmune Disease Diagnostics Global Market Outlook Report - A $17.9 Billion Market by 2028 - ResearchAndMarkets.com

Retrieved on: 
Thursday, December 28, 2023
Health, Other Health, BioMérieux, Autoimmune disease, ESG, Thermo Fisher Scientific, Siemens Healthineers, Pharmaceutical industry

The "Autoimmune Disease Diagnostics: Global Markets" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Autoimmune Disease Diagnostics: Global Markets" report has been added to ResearchAndMarkets.com's offering.
  • The global autoimmune disease diagnostics market was valued at nearly $14.2 billion in 2022.
  • The market is expected to grow at a compound annual growth rate (CAGR) of 3.9%, reaching $17.9 billion by 2028.
  • This report aims to study the autoimmune disease diagnostics global market size comprehensively.

Food Diagnostics Market worth $23.5 billion by 2028 - Exclusive Report by MarketsandMarkets™

Retrieved on: 
Wednesday, November 1, 2023
System, BioMérieux, Laboratory, FDA, Shimadzu, Food safety, Escherichia coli, CFIA, Tradition, Health, Food, Pesticide, Poultry, Meat, Region, Salmonella, PCR, Dairy, Cereals & Grains Association, Campylobacter, Growth, Thermo Fisher Scientific, Cereal, Agilent Technologies, Risk, Allergen, Merck Group, Standard Barrel Act For Fruits, Vegetables, and Dry Commodities, Food quality, USD, Public, Safety, QIAGEN, Vegetable, Pharmaceutical industry, Pet industry, Medical device, Listeria, Seafood

Food diagnostics involves a range of techniques and technologies used to detect contaminants, pathogens, allergens, and adulterants in food products.

Key Points: 
  • Food diagnostics involves a range of techniques and technologies used to detect contaminants, pathogens, allergens, and adulterants in food products.
  • By food tested, the fruits & vegetables segment is anticipated to grow at a significant rate in the food diagnostics market.
  • North America is estimated to have a significant market share in the global food diagnostics market.
  • Consequently, the market for food diagnostics services has witnessed substantial growth as it offers consumers the assurance and peace of mind they seek when making food choices.

Global Clinical Workflow Solutions Market Size, Share & Trends Analysis Report 2023: Data Integration Solutions Dominated in 2022 with 26.53% Market Share - Global Forecasts to 2030 - ResearchAndMarkets.com

Retrieved on: 
Monday, September 18, 2023
Data Analytics, Health Technology, Professional Services, Health, Data management, Hospital, Roche, COVID-19, AHS, Provat Lakra, Privacy, USD, Fortive, Organization, CWA, State, Acquisition, EHR, BioMérieux, Electronic health record, Growth, Automation, Nursing, Health care, Pharmaceutical industry, Medical device

The "Clinical Workflow Solutions Market Size, Share & Trends Analysis Report By Type (Data Integration Solutions, Workflow Automation Solutions), By End-use (Hospitals, Ambulatory Care Centers), By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Clinical Workflow Solutions Market Size, Share & Trends Analysis Report By Type (Data Integration Solutions, Workflow Automation Solutions), By End-use (Hospitals, Ambulatory Care Centers), By Region, And Segment Forecasts, 2023 - 2030" report has been added to ResearchAndMarkets.com's offering.
  • The global clinical workflow solutions market size is estimated to reach USD 24.37 billion by 2030, growing at a CAGR of 12.4%.
  • Based on type, the data integration solutions category dominated the market with a share of 26.53% in 2022.
  • For instance, Innovaccer and Roche announced a collaboration to provide clinical decision support and workflow solutions in September 2021.

Global In-Vitro Diagnostics Market Report 2023-2028: Rising Demand for Automated IVD Systems in Hospitals & Laboratories - ResearchAndMarkets.com

Retrieved on: 
Monday, August 14, 2023
Infectious Diseases, Health, Other Health, Infection, Hepatitis, Laboratory, Prevalence, Medicine, Siemens Healthineers, Bio-Rad Laboratories, Hospital, Tuberculosis, BioMérieux, IVD, Conditional sentence, Growth, Pneumonia, Porter's five forces analysis, Medical device, Qiagen

The "In-Vitro Diagnostics Market: Trends, Opportunities and Competitive Analysis 2023-2028" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "In-Vitro Diagnostics Market: Trends, Opportunities and Competitive Analysis 2023-2028" report has been added to ResearchAndMarkets.com's offering.
  • The global in-vitro diagnostics market is expected to witness a promising future, with opportunities in the hospitals, laboratories, and home care end-use industries.
  • The market is projected to reach an estimated value of $127.3 billion by 2028, growing at a CAGR of 5% from 2023 to 2028.
  • The major drivers of this growth are the increasing prevalence of chronic diseases and the rising demand for automated IVD systems in hospitals and laboratories to ensure accurate, error-free, and efficient diagnoses.

Nephron Announces Julie Rameas as Chief Procurement Officer

Retrieved on: 
Thursday, August 17, 2023
Nephron, Chemistry, Lear Corporation, Growth, Ground substance, Bachelor of Science, Ramea, Hospital, IV, Textile, Thermo Fisher Scientific, BioMérieux, Indiana University of Pennsylvania, Management, Science

WEST COLUMBIA, S.C., Aug. 17, 2023 /PRNewswire/ -- Nephron Pharmaceuticals Corporation today announced Julie Rameas as Chief Procurement Officer.

Key Points: 
  • WEST COLUMBIA, S.C., Aug. 17, 2023 /PRNewswire/ -- Nephron Pharmaceuticals Corporation today announced Julie Rameas as Chief Procurement Officer.
  • In her new role, Rameas will oversee all strategic sourcing and procurement activities.
  • Her rock star resume and body of work speaks for itself," said Nephron CEO and Owner Lou Kennedy.
  • Before joining the Nephron team, Rameas served as Senior Director of Global Strategic Procurement at Thermo Fisher Scientific, where she led spending activities for over 800 global sites, and managed multiple global expansion and construction projects.

Veterinary Antimicrobial Susceptibility Testing Global Market Report 2023: Rising Prevalence of Zoonotic Diseases Fuels Demand - ResearchAndMarkets.com

Retrieved on: 
Tuesday, July 25, 2023
Veterinary, Health, Human, Diagnosis, Prevalence, Infection, Zoonosis, World Health Organization, USD, Sale, Organization, Animal, Acquisition, BioMérieux, Algorithm, Growth, AST, Geography, Vaccine

The "Veterinary Antimicrobial Susceptibility Testing Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Veterinary Antimicrobial Susceptibility Testing Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.
  • Technological advancements have emerged as a key trend gaining popularity in the veterinary antimicrobial susceptibility testing market.
  • The rising prevalence of zoonotic diseases is expected to propel the growth of the veterinary antimicrobial susceptibility testing market going forward.
  • Therefore, the increasing prevalence of zoonotic diseases is driving the growth of the veterinary antimicrobial susceptibility testing market.

Global Veterinary Antimicrobial Susceptibility Testing Market Report 2023-2032

Retrieved on: 
Monday, July 24, 2023
Human, Diagnosis, Prevalence, Veterinarian, Infection, Zoonosis, World Health Organization, USD, Sale, Organization, Animal, Acquisition, BioMérieux, Algorithm, Growth, AST, Geography, Vaccine

DUBLIN, July 24, 2023 /PRNewswire/ -- The "Veterinary Antimicrobial Susceptibility Testing Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, July 24, 2023 /PRNewswire/ -- The "Veterinary Antimicrobial Susceptibility Testing Global Market Report 2023" report has been added to ResearchAndMarkets.com's offering.
  • The veterinary antimicrobial susceptibility testing market is set to witness remarkable growth in the coming years, driven by technological advancements and innovative solutions.
  • The countries covered in the veterinary antimicrobial susceptibility testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
  • The rising prevalence of zoonotic diseases is expected to propel the growth of the veterinary antimicrobial susceptibility testing market going forward.